News and ViewsIs Enliven Therapeutics, Inc. technically bullish or bearish?
2025-11-05 11:24:44As of 31 October 2025, the technical trend for Enliven Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating positive momentum. The daily moving averages are mildly bullish, supporting the overall bullish stance. However, the weekly KST and Bollinger Bands present some bearish signals, and the RSI shows no signal on both weekly and monthly time frames. In terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of -15.51% compared to the S&P 500's 16.30%, and a one-year return of -31.20% versus the S&P 500's 19.89%. Overall, the current technical stance is bullish but with caution due to mixed signals from some indicators....
Read MoreIs Enliven Therapeutics, Inc. technically bullish or bearish?
2025-11-04 11:36:39As of 31 October 2025, the technical trend for Enliven Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Daily moving averages indicate a mildly bullish stance. However, the weekly Bollinger Bands are bearish, and both the KST and Dow Theory show a mildly bullish trend on the weekly and monthly time frames. In terms of performance, the stock has underperformed the S&P 500 over the past year and year-to-date, with returns of -27.61% and -11.11% respectively, while the S&P 500 has returned 19.89% and 16.30%. Overall, the current technical stance is bullish, but the strength is mixed due to conflicting indicators....
Read MoreIs Enliven Therapeutics, Inc. technically bullish or bearish?
2025-11-02 11:20:14As of 31 October 2025, the technical trend for Enliven Therapeutics, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish. Daily moving averages also indicate a bullish trend. However, the KST shows a mildly bearish signal on both weekly and monthly time frames, which suggests some caution. In terms of performance, the stock has outperformed the S&P 500 significantly over the past week (13.63% vs. 0.71%) and month (18.13% vs. 1.92%), but has underperformed over the longer term, with a 1-year return of -15.91% compared to the S&P 500's 19.89%. Overall, the technical indicators suggest a bullish outlook, albeit with some mixed signals in the longer-term trends....
Read MoreIs Enliven Therapeutics, Inc. technically bullish or bearish?
2025-10-07 12:26:21As of 3 October 2025, the technical trend for Enliven Therapeutics, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the MACD on a monthly basis and mildly bearish signals from the daily moving averages and KST. The stock has underperformed the S&P 500 significantly over the past year, with a return of -26.26% compared to the S&P 500's 17.82%. Overall, the indicators suggest a negative outlook for the stock in the near term....
Read MoreIs Enliven Therapeutics, Inc. technically bullish or bearish?
2025-10-05 12:02:11As of 3 October 2025, the technical trend for Enliven Therapeutics, Inc. has changed from mildly bearish to bearish. The current stance is bearish with strong indicators supporting this view, including bearish MACD readings on both weekly and monthly time frames, a bearish daily moving average, and a bearish KST on the weekly chart. The Bollinger Bands indicate a bearish trend on the weekly and a sideways trend on the monthly. The Dow Theory shows a mildly bullish signal on the weekly but no trend on the monthly, which contrasts with the overall bearish indicators. In terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of -12.84% compared to the S&P 500's 14.18%, and a one-year return of -23.13% versus 17.82% for the index....
Read MoreIs Enliven Therapeutics, Inc. technically bullish or bearish?
2025-09-30 11:19:39As of 26 September 2025, the technical trend for Enliven Therapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by bearish MACD readings on both weekly and monthly time frames, along with a mildly bearish indication from moving averages on the daily chart. The KST and OBV also reflect a mildly bearish trend on the weekly, while the Bollinger Bands show a sideways movement weekly and bearish monthly. In terms of performance, the stock has underperformed against the S&P 500 over the past month, year-to-date, and year, with returns of -1.53%, -11.07%, and -17.04% respectively, while the S&P 500 has returned 2.75%, 12.96%, and 15.64% in those periods. However, it has significantly outperformed the benchmark over the 3-year period with a return of 848.34% compared to 81.77% for the S&P 500....
Read MoreIs Enliven Therapeutics, Inc. technically bullish or bearish?
2025-09-29 11:20:27As of 26 September 2025, the technical trend for Enliven Therapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, supported by bearish MACD readings on both weekly and monthly time frames, and a mildly bearish signal from the daily moving averages. The Bollinger Bands indicate a sideways movement on the weekly chart and a bearish trend on the monthly chart. Additionally, the KST and OBV are both mildly bearish on a weekly basis, while the Dow Theory shows a mildly bearish stance on the weekly chart with no trend on the monthly. In terms of performance, the stock has returned 5.54% over the past week, outperforming the S&P 500, which returned -0.31%. However, over the longer term, the stock has underperformed the S&P 500 with a year-to-date return of -11.07% compared to the S&P's 12.96%, and a one-year return of -17.04% versus 15.64% for the index....
Read MoreIs Enliven Therapeutics, Inc. technically bullish or bearish?
2025-09-28 11:13:25As of 26 September 2025, the technical trend for Enliven Therapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by weekly and monthly MACD readings both indicating bearish momentum, alongside a bearish monthly Bollinger Band. The daily moving averages also reflect a mildly bearish trend. The KST and OBV indicators are mildly bearish on a weekly basis, while the Dow Theory shows a mildly bearish trend on the weekly timeframe with no trend on the monthly. In terms of performance, the stock has returned 5.54% over the past week, outperforming the S&P 500, which declined by 0.31%. However, over the longer term, the stock has underperformed significantly, with a year-to-date return of -11.07% compared to the S&P 500's 12.96%, and a one-year return of -17.04% versus the S&P 500's 15.64%....
Read MoreIs Enliven Therapeutics, Inc. technically bullish or bearish?
2025-09-20 20:26:25As of 11 September 2025, the technical trend for Enliven Therapeutics, Inc. has changed from bearish to mildly bearish. The MACD indicates a bearish stance on both weekly and monthly time frames, while the RSI shows no signal for either period. Bollinger Bands are sideways on the weekly and bearish on the monthly, and moving averages are bearish on the daily. KST and Dow Theory both reflect a mildly bearish outlook on the weekly, with Dow Theory showing no trend on the monthly. In terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of -11.44% compared to the S&P 500's 12.22%, and a one-year return of -8.43% versus 17.14%. Overall, the current technical stance is mildly bearish....
Read More
Announcement
Corporate ActionsCorporate Actions
